In the closing months of 2013, some of the partnerships focused on the development, manufacture, and commercialization of biosimilars took steps toward regulated market competition, while other faced hurdles. Coherus Bosciences Inc, which teamed up with Baxter international to develop and commercialize a version of Amgen’s Enbrel (etanercept), announced positive results from a clinical study […]
written on 14.04.2014
Developments in Biosimilars
